4.7 Letter

Reporting of Immune Checkpoint Inhibitor Therapy-Associated Diabetes, 2015-2019

Journal

DIABETES CARE
Volume 43, Issue 7, Pages E79-E80

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dc20-0459

Keywords

-

Funding

  1. National Key R&D Program of China [2016YFC0905500, 2016YFC0905503]
  2. Science and Technology Program of Guangdong [2017B020227001]
  3. Chinese National Natural Science Foundation [81872499, 81572659, 81772476]
  4. Science and Technology Program of Guangzhou [201607020031, 201704020072]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available